isoproterenol has been researched along with punicalagin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boukholda, K; Chigr, F; Chtourou, Y; Fetoui, H; Fiebich, BL; Jghef, MM; Kebieche, M; Soulimani, R | 1 |
1 other study(ies) available for isoproterenol and punicalagin
| Article | Year |
|---|---|
Punicalagin attenuates myocardial oxidative damage, inflammation, and apoptosis in isoproterenol-induced myocardial infarction in rats: Biochemical, immunohistochemical, and in silico molecular docking studies.
Topics: Animals; Antioxidants; Apoptosis; Cytokines; Hydrolyzable Tannins; Inflammation; Isoproterenol; Molecular Docking Simulation; Myocardial Infarction; Myocardium; NF-E2-Related Factor 2; Oxidative Stress; Rats | 2023 |